What is Galenica's history?
Galenica’s history spans nearly a century, dating back to 1927 when 16 pharmacists in Clarens, Switzerland, founded the Collaboration Pharmaceutique SA as a joint purchasing center. Over the decades, the company evolved through significant diversification and strategic acquisitions. By the 1950s and 1970s, it had expanded into pharmaceutical production, parapharmaceuticals, and prescription-free (OTC) drugs. A major milestone occurred in 2008 with the acquisition of Aspreva Pharmaceuticals, which helped build the specialized Vifor Pharma division. In 2014, the company was divided into two distinct groups, Vifor Pharma and Galenica Santé, ultimately leading to their separation. Since 2017, Galenica has been listed on the Swiss stock exchange as an independent entity, focusing on its core strengths in pharmacy chains, healthcare logistics, and patient homecare.
Related FAQs
"Gale" refers to the stock ticker symbol for Galenica AG (GALE.SW), a major Swiss-based pharmaceutical and logistics company headquartered in Bern.
GEA Group contributes significantly to global food processing and industrial manufacturing by engineering, designing, and supplying advanced processing technology, components, and comprehensive production lines.
Galenica operates primarily as a leading Swiss healthcare, logistics, and pharmacy network group rather than a conventional drug manufacturing pharmaceutical enterprise.
Investing in the rare earth elements sector involves identifying companies that control critical mineral reserves and advanced magnet manufacturing facilities essential for electric vehicles and defense technology.
Galenica AG is a fully public corporate entity whose shares are officially listed and traded on the SIX Swiss Exchange under the ticker symbol GALE, and it serves as a component of the prominent SMI MID index.
According to the latest financial reporting data available as of August 2026, Galenica AG recorded an annual revenue of approximately ₹502.93 billion for the year 2025. This figure represents a notable growth of 20.
Galenica AG operates as a leading fully integrated healthcare enterprise in Switzerland, focusing its core business activities on pharmaceutical distribution, retail pharmacy operations, and specialized health-related services.
Galenica AG, a leading fully integrated healthcare provider, pharmaceutical distributor, and pharmacy network operator in Switzerland, has its corporate headquarters located in Bern, Switzerland.
Galenica Ltd maintains its corporate headquarters at Untermattweg 8, 3027 Bern, Switzerland.